TY - BOOK AU - National Academies of Sciences, Engineering, and Medicine A2 - V. Ayano Ogawa A2 - Cecilia Mundaca Shah A2 - Anna Nicholson TI - Exploring Lessons Learned from a Century of Outbreaks: Readiness for 2030: Proceedings of a Workshop SN - DO - 10.17226/25391 PY - 2019 UR - https://nap.nationalacademies.org/catalog/25391/exploring-lessons-learned-from-a-century-of-outbreaks-readiness-for PB - The National Academies Press CY - Washington, DC LA - English KW - Health and Medicine AB - In November 2018, an ad hoc planning committee at the National Academies of Sciences, Engineering, and Medicine planned two sister workshops held in Washington, DC, to examine the lessons from influenza pandemics and other major outbreaks, understand the extent to which the lessons have been learned, and discuss how they could be applied further to ensure that countries are sufficiently ready for future pandemics. This publication summarizes the presentations and discussions from both workshops. ER - TY - BOOK AU - National Academy of Sciences A2 - Rita S. Guenther A2 - Micah D. Lowenthal TI - Indo-U.S. Workshop on Challenges of Emerging Infections and Global Health Safety: Summary of a Workshop SN - DO - 10.17226/21810 PY - 2016 UR - https://nap.nationalacademies.org/catalog/21810/indo-us-workshop-on-challenges-of-emerging-infections-and-global-health-safety PB - The National Academies Press CY - Washington, DC LA - English KW - Health and Medicine AB - The United States and India have pledged to deepen the linkages between their people, their businesses, and their governments for the mutual benefit of both countries and for the promotion of global peace, stability, economic growth and prosperity. Both nations are now inclined to improve relations and cooperation, but the nations need specific actions that will yield progress and build confidence and momentum for further cooperation. The Indo-U.S. Workshop on Challenges of Emerging Infections and Global Health Safety, held in November 2014, encouraged scientists from both countries to examine global issues related to emerging and existing infections and global health safety, to share experience and approaches, and to identify opportunities for cooperation to improve practice and research in these areas. This report summarizes the presentations and discussions from the workshop. ER - TY - BOOK AU - National Research Council TI - Countering Biological Threats: Challenges for the Department of Defense's Nonproliferation Program Beyond the Former Soviet Union SN - DO - 10.17226/12596 PY - 2009 UR - https://nap.nationalacademies.org/catalog/12596/countering-biological-threats-challenges-for-the-department-of-defenses-nonproliferation PB - The National Academies Press CY - Washington, DC LA - English KW - Conflict and Security Issues AB - In response to a request from the U.S. Congress, this book examines how the unique experience and extensive capabilities of the Department of Defense (DOD) can be extended to reduce the threat of bioterrorism within developing countries outside the former Soviet Union (FSU). During the past 12 years, DOD has invested $800 million in reducing the risk from bioterrorism with roots in the states of the FSU. The program's accomplishments are many fold. The risk of bioterrorism in other countries is too great for DOD not to be among the leaders in addressing threats beyond the FSU. Taking into account possible sensitivities about a U.S. military presence, DOD should engage interested governments in about ten developing countries outside the FSU in biological threat reduction programs during the next five years. Whenever possible, DOD should partner with other organizations that have well established humanitarian reputations in the countries of interest. For example, the U.S. Agency for International Development, the Centers for Disease Control and Prevention, and the World Health Organization should be considered as potential partners. ER - TY - BOOK AU - Institute of Medicine A2 - David A. Relman A2 - Eileen R. Choffnes A2 - Alison Mack TI - The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions: Workshop Summary SN - DO - 10.17226/12799 PY - 2010 UR - https://nap.nationalacademies.org/catalog/12799/the-domestic-and-international-impacts-of-the-2009-h1n1-influenza-a-pandemic PB - The National Academies Press CY - Washington, DC LA - English KW - Health and Medicine AB - In March and early April 2009, a new, swine-origin 2009-H1N1 influenza A virus emerged in Mexico and the United States. During the first few weeks of surveillance, the virus spread by human-to-human transmission worldwide to over 30 countries. On June 11, 2009, the World Health Organization (WHO) raised the worldwide pandemic alert level to Phase 6 in response to the ongoing global spread of the novel influenza A (H1N1) virus. By October 30, 2009, the H1N1 influenza A had spread to 191 countries and resulted in 5,700 fatalities. A national emergency was declared in the United States and the swine flu joined SARS and the avian flu as pandemics of the 21st century. Vaccination is currently available, but in limited supply, and with a 60 percent effectiveness rate against the virus. The story of how this new influenza virus spread out of Mexico to other parts of North America and then on to Europe, the Far East, and now Australia and the Pacific Rim countries has its origins in the global interconnectedness of travel, trade, and tourism. Given the rapid spread of the virus, the international scientific, public health, security, and policy communities had to mobilize quickly to characterize this unique virus and address its potential effects. The World Health Organization and Centers for Disease Control have played critical roles in the surveillance, detection and responses to the H1N1 virus. The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions aimed to examine the evolutionary origins of the H1N1 virus and evaluate its potential public health and socioeconomic consequences, while monitoring and mitigating the impact of a fast-moving pandemic. The rapporteurs for this workshop reported on the need for increased and geographically robust global influenza vaccine production capacities; enhanced and sustained interpandemic demand for seasonal influenza vaccines; clear "triggers" for pandemic alert levels; and accelerated research collaboration on new vaccine manufacturing techniques. This book will be an essential guide for healthcare professionals, policymakers, drug manufacturers and investigators. ER -